Status:
COMPLETED
Injured Spinal Cord Pressure Evaluation Study - Transverse Myelitis
Lead Sponsor:
St George's, University of London
Collaborating Sponsors:
Wings for Life
Neurosciences Research Foundation
Conditions:
Transverse Myelitis
Eligibility:
All Genders
18-70 years
Brief Summary
ISCoPE-TM will use intra spinal monitoring techniques to assess cord perfusion and metabolism in patients with severe spinal cord damage from transverse myelitis
Detailed Description
Transverse myelitis (TM) is a rare inflammatory condition of the spinal cord. It is characterised by rapid onset of motor, sensory or autonomic dysfunction causing neurological deficit. It has a diver...
Eligibility Criteria
Inclusion
- Transverse myelitis (as defined by TM working group 2002)
- MRI evidence of swollen enlarged spinal cord. Defined as a larger cord diameter compared to the adjacent normal signal intensity spinal cord, with loss of cerebrospinal fluid space between cord and dura mater.
- Age 18 - 70
- Severe spinal cord injury (ASIA A - B)
- Monitoring to start within 72 h of MRI
- Capacity for informed consent
Exclusion
- Major co-morbidities likely to influence outcome
- High anaesthetic risk precluding surgery
- Multiple separate lesions on MRI spine
- Lacking capacity or Unable to consent
- Pregnancy
Key Trial Info
Start Date :
February 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03336762
Start Date
February 14 2017
End Date
August 1 2020
Last Update
January 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St George's, University of London
London, United Kingdom, SW17 0RE